🚀 ProPicks AI Hits +34.9% Return!Read Now

I’d buy these 2 cheap UK shares today to make a million

Published 12/07/2020, 11:29
Updated 12/07/2020, 11:40
I’d buy these 2 cheap UK shares today to make a million
UK100
-
LGEN
-

Despite the stock market’s positive performance over the past few weeks, there are still plenty of cheap UK shares on offer for investors in the market.

Companies like the two profiled below could help investors grow their wealth and put them well on the way to making a million.

Cheap UK shares to buy Legal & General Group (LSE: LON:LGEN) is one of the top income investments in the FTSE 100. Shares in the financial services giant have risen steadily in value over the past few weeks. Despite this performance, the stock continues to look cheap.

As one of the world’s largest asset managers, Legal has been impacted by the coronavirus crisis. Nevertheless, of all the cheap UK shares, the stock may have been affected by the pandemic to a lesser degree. The corporation registered an impressive jump in new business during the first quarter of the year.

Management also came out to announce the company would be standing by its dividend commitments. This was highly impressive, considering the backdrop the organisation faced and suggests Legal’s business is stable. In its final dividend, the firm paid out around £750m to shareholders.

As one of the country’s largest pension managers, L&G should continue to see high demand for its services. That should support further dividend and earnings growth in the years ahead, which makes the company stand out as one of the top cheap UK shares.

As such, now could be the perfect time to snap up a share of this dividend champion while it trades around 25% below the level it started the year.

AstraZeneca AstraZeneca (LSE: AZN) is another cheap stock I’d consider buying today. As one of the world’s largest pharmaceutical corporations, Astra operates a relatively defensive business model. It’s also in line to be one of the first pharmaceutical companies to produce a coronavirus vaccine. If successful, this could have a large impact on the organisation’s bottom line.

Cheap UK shares like AstraZeneca’s don’t come around that often. The company is currently trading at a forward price-to-earnings (P/E) multiple of 21. That’s compared to a P/E of more than 30 for some of the business’s US-listed peers.

These numbers suggest the stock may offer a margin of safety and the potential to produce substantial capital returns from current levels. On top of this capital gains potential, the stock also supports a dividend yield of 2.6%.

Unlike most cheap UK shares, Astra hasn’t cut its dividend recently. And it doesn’t look as if it’ll have to either. The payout is covered 1.5 times by earnings per share, which gives the group lots of headroom to maintain, or increase, the payout.

Therefore, if you’re looking for cheap UK shares that may be able to produce high total returns for your portfolio, it might be a good idea to consider buying Astra today.

The post I’d buy these 2 cheap UK shares today to make a million appeared first on The Motley Fool UK.

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Motley Fool UK 2020

First published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.